Chinese Clinical Trial Register (ChiCTR) - The world health organization international clinical trials registered organization registered platform

Today is 2022-07-06

简体中文|English

Trial search

Filter Options
Public title		Scientific title		Subject ID
Registration Status		Registration number		Secondary ID
Applicant		Study leader		Year
Primary sponsor		Secondary sponsor		Source(s) of funding
Target disease		Target disease code		Study type
Study phase		Study design		Study execute time	From To
Recruiting status		Gender		Sign the informed consent
Countries of recruitment and research settings	Nation(Area)：Province：City： Institution：Level of the institution：
Intervention		Intervention code		Approved by ethic committee
Calculated Results after the Study Completed public access		Statistical results after completion of the test file upload
	More Options

13 trials have been registered

Historical versions	Registration number	Public title	Type	Registration time
Historical Versions	ChiCTR2100045273	Safety and efficacy of tocilizumab in the treatment of recurrent optic neuritis Department of Ophthalmology, PLA General Hospital	Interventional	2021/04/10
Historical Versions	ChiCTR2100044103	Epirubicin-loaded microspheres TACE combined with tocilizumab in the treatment of stage III hepatocellular carcinoma Qingdao University Affiliated Hospital	Observational	2021/03/11
Historical Versions	ChiCTR2100043273	Efficacy and safety of tocilizumab in the treatment of generalizaed myasthenia gravis: a single-center, prospective cohort study Department of Neurology, The Second Affiliated Hospital of Air Force Medical University	Observational	2021/02/09
Historical Versions	ChiCTR2000033705	A medical records based study for the preliminary efficacy of Tocilizumab in the treatment of the patients with novel coronavirus pneumonia (COVID-19) Xijing Hospital	Observational	2020/06/10
Historical Versions	ChiCTR2000032678	A multicenter, non-interventional, prospective study of the safety and efficacy of tocilizumab in the treatment of rheumatoid arthritis in the real world Peking Union Medical College Hospital, Chinese Academy of Medical Sciences	Observational	2020/05/06
Historical Versions	ChiCTR2000030894	Favipiravir Combined With Tocilizumab in the Treatment of novel coronavirus pneumonia (COVID-19) - A Multicenter, Randomized, Controlled Trial Peking University First Hospital	Interventional	2020/03/16
Historical Versions	ChiCTR2000029765	A multicenter, randomized controlled trial for the efficacy and safety of tocilizumab in the treatment of new coronavirus pneumonia (COVID-19) The First Affiliated Hospital of University of science and technology of China (Anhui Provincial Hospital)	Interventional	2020/02/13
Historical Versions	ChiCTR1900021808	A Phase 1, Randomized, Double-Blind and Paralle, Controlled Single-dose Clinical Trial of Pharmacokinetic, Safety, Tolerability and Immunogenicity Study of QX003S and Tocilizumab in Chinese Health Male Subjects JiangSu Qyuns Therapeutics Co., Ltd	Interventional	2019/03/11
Historical Versions	ChiCTR1800015472	A single arm,single-center clinical study of tocilizumab in the treatment of corticosteroids unresponsive pre-engraftment syndrome patients after unrelated cord blood transplantation Anhui Provincial Hospital	Interventional	2018/04/01
Historical Versions	ChiCTR-OPB-17013704	A phase IV, multicenter single-arm, open-label study to assess the efficecy and safety of Tocilizumab in Chinese patients with systemic juvenile idiopathic arthritis Children's Hospital of Chongqing Medical University	Observational	2017/12/05

First 1 2 Next Last No.1\Total 2

临床试验公共管理平台 Clinical Trial Management Public Platform

中国注册临床试验伦理审查委员会 chinese ethics committee of registering clinical trials

医学期刊出版与编辑伦理网 Medical Journal Publication and Edite Ethics Network

欢迎访问WHO国际临床试验注册平台

Clinical Trials Hong Kong

Ottawa Statement on Trial Registration

北京针灸临床试验注册中心

Home|
About ChiCTR|
Trial Search|
Document|
Reg guide|
Question